Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 8/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | BTK | Q06187 | 1/20 | 0.70 |
| ▸ | TUBB4A | P04350 | 4/20 | 0.66 |
| ▸ | TUBB | P07437 | 4/20 | 0.66 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.66 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.66 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.66 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.66 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.66 |
| ▸ | TUBB2A | Q13885 | 4/20 | 0.66 |
| ▸ | TUBB8 | Q3ZCM7 | 4/20 | 0.66 |
| ▸ | TUBA3E | Q6PEY2 | 4/20 | 0.66 |
| ▸ | TUBA1A | Q71U36 | 4/20 | 0.66 |
| ▸ | TUBA1C | Q9BQE3 | 4/20 | 0.66 |
| ▸ | TUBB6 | Q9BUF5 | 4/20 | 0.66 |
| ▸ | TUBB2B | Q9BVA1 | 4/20 | 0.66 |
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4082306 | 0.89 | TUBB4A (0.66) | IKBKBCYP1A2CYP3A4CYP2C9BTK | |
| SCHEMBL4081426 | 0.87 | MAPT (0.67) | IKBKBCYP1A2CYP3A4CYP2C9BTK | |
| SCHEMBL4097204 | 0.87 | IKBKB (1.00) | IKBKBCYP1A2CYP3A4CYP2C9BTK | |
| SCHEMBL1847243 | 0.83 | IKBKB (1.00) | IKBKBCYP1A2CYP3A4CYP2C9BTK | |
| SCHEMBL6607937 | 0.82 | IKBKB (0.74) | IKBKBCYP1A2CYP3A4CYP2C9BTK | |
| SCHEMBL6609956 | 0.82 | IKBKB (0.79) | IKBKBCYP1A2CYP3A4CYP2C9BTK | |
| SCHEMBL1383137 | 0.81 | IKBKB (1.00) | IKBKBMAPTKDM4ELMNAALDH1A1 | |
| SCHEMBL6608181 | 0.81 | IKBKB (0.77) | IKBKBCYP1A2CYP3A4CYP2C9BTK | |
| SCHEMBL4086753 | 0.79 | IKBKB (0.75) | IKBKBCYP1A2CYP3A4CYP2C9BTK | |
| SCHEMBL5605815 | 0.79 | HDAC6 (0.56) | IKBKBTUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1444010-A2 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION | Pharmacia Corporation (US) | 2004-08-11 | — | — | EP | claimed |
| WO-2003037886-A2 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION | PHARMACIA CORPORATION (US) | 2003-05-08 | — | — | WO | claimed |
| US-20090181962-A1 | Substituted thiophene compounds | ASTRAZENECA AB, A SWEDEN CORPORATION | 2009-07-16 | — | — | US | disclosed |
| US-7358376-B2 | Substituted Thiophene compounds | ASTRAZENECA AB (SE) | 2008-04-15 | — | — | US | disclosed |
| CN-1243747-C | Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 | ASTRAZENECA AB (SE) | 2006-03-01 | — | — | CN | disclosed |
| EP-1444010-A2 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION | Pharmacia Corporation (US) | 2004-08-11 | — | — | EP | disclosed |
| EP-1261600-B1 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2 | ASTRAZENECA AB (SE) | 2004-05-06 | — | — | EP | disclosed |
| CN-1425012-A | Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 | ASTRAZENECA AB (SE) | 2003-06-18 | — | — | CN | disclosed |
| WO-2003037886-A2 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION | PHARMACIA CORPORATION (US) | 2003-05-08 | — | — | WO | disclosed |
| EP-1261600-A1 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2 | AstraZeneca AB (SE) | 2002-12-04 | — | — | EP | disclosed |
| US-20020107252-A1 | Novel Compounds | ASTRAZENECA AB (SE) | 2002-08-08 | — | — | US | disclosed |
| WO-2001058890-A1 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2 | ASTRAZENECA AB (SE) | 2001-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181962-A1 | Substituted thiophene compounds | ABCG2, SULT1E1, TPMT | IKBKB 3065/4885CYP1A2 4/4885CYP3A4 8/4885 |
| US-20020107252-A1 | Novel Compounds | UGT1A1, CYP1B1, CYP1A1 | IKBKB 2413/4885CYP1A2 4/4885CYP3A4 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.